Tuesday, October 19

FDA approves Mirum Pharma’s drug for itching associated with rare liver disorder

Article content

Mirum Pharmaceuticals Inc said

on Wednesday that the US Food and Drug Administration has

approved its drug to treat itching in patients with Alagille

syndrome, making it the first approved therapy for treating

symptoms of the genetic disorder.

(Reporting by Mrinalika Roy and Bhanvi Satija in Bengaluru;

Editing by Shinjini Ganguli)


Leave a Reply

Your email address will not be published. Required fields are marked *